The association between cytomegalovirus-specific antibodies, lymphocytotoxic antibodies, HLA-DR phenotype, and graft outcome in renal transplant recipients.
Martin
S
S
Northwest Regional Tissue Typing Laboratory, St Mary's Hospital, Manchester, United Kingdom.
Morris
D
D
Dyer
P A
PA
Gokal
R
R
Mallick
N P
NP
Johnson
R W
RW
D000914:Antibodies, Viral / Q000276:immunology*; D000961:Antilymphocyte Serum / Q000276:immunology*; D003587:Cytomegalovirus / Q000276:immunology*; D006085:Graft Survival; D006684:HLA-DR Antigens / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D011379:Prognosis
D000914:Antibodies, Viral; D000961:Antilymphocyte Serum; D006684:HLA-DR Antigens